Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: valspodar
Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)